Amoy Diagnostics Co., Ltd.
SHZ: 300685.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Jiemin Luo
- Employees
- 1,144
- Headquarters
- Xiamen, China
- IPO year
- 2017
- Market cap
- CN¥7.9B
- Website
- https://www.amoydx.com
Loading 300685…
Loading profile data…Frequently asked questions about 300685
What does Amoy Diagnostics Co., Ltd. (300685.SZ) do?
Amoy Diagnostics Co., Ltd., a diagnostic company, focuses on molecular diagnostics for oncology precision medicine in China and internationally. The company offers NGS, real-time PCR, FISH, and extraction assays. Amoy Diagnostics Co., Ltd. was founded in 2008 and is based in Xiamen, China.
Where does 300685.SZ trade?
Amoy Diagnostics Co., Ltd. (300685.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300685.SZ in?
Amoy Diagnostics Co., Ltd. (300685.SZ) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Amoy Diagnostics Co., Ltd.?
Jiemin Luo is the chief executive officer of Amoy Diagnostics Co., Ltd. (300685.SZ).
Where is Amoy Diagnostics Co., Ltd. headquartered?
Amoy Diagnostics Co., Ltd. is headquartered in China.
Does 300685.SZ pay a dividend?
Yes — Amoy Diagnostics Co., Ltd. (300685.SZ) paid a trailing twelve-month dividend of CNY 0.30 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300685.SZ go public?
Amoy Diagnostics Co., Ltd. (300685.SZ) completed its initial public offering in 2017.